Use of a rare disease patient registry in long-term post-authorisation drug studies: a model for collaboration with industry

Diana Bilton, Noreen Caine, Steve Cunningham, Nicholas J Simmonds, Rebecca Cosgriff, Siobhán B Carr

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalThe Lancet Respiratory Medicine
Early online date4 May 2018
Publication statusE-pub ahead of print - 4 May 2018

Cite this